1	Lymphocyte	Lymphocyte	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	lines	line	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	vitamin	vitamin	_	_	_	_	_	_	_
6	D-dependent	d-dependent	_	_	_	_	_	_	_
7	rickets	ricket	_	_	_	_	_	_	_
8	type	type	_	_	_	_	_	_	_
9	II	ii	_	_	_	_	_	_	_
10	show	show	_	_	_	_	_	_	_
11	functional	functional	_	_	_	_	_	_	_
12	defects	defect	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	1	1	_	_	_	_	_	_	_
16	alpha,25-dihydroxyvitamin	alpha,25-dihydroxyvitamin	_	_	_	_	_	_	_
17	D3	d3	_	_	_	_	_	_	_
18	receptor	receptor	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Lymphocyte	Lymphocyte	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	lines	line	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	established	establish	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	five	five	_	_	_	_	_	_	_
8	patients	patient	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	vitamin	vitamin	_	_	_	_	_	_	_
11	D-dependent	d-dependent	_	_	_	_	_	_	_
12	rickets	ricket	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	type	type	_	_	_	_	_	_	_
15	II	ii	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	VDDR-II	VDDR-II	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	lines	line	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	established	establish	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	infection	infection	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	T-lymphotrophic	t-lymphotrophic	_	_	_	_	_	_	_
10	virus	virus	_	_	_	_	_	_	_
11	type	type	_	_	_	_	_	_	_
12	I	i	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	HTLV-I	HTLV-I	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	[	[	_	_	_	_	_	_	_
4	3H]1	3h]1	_	_	_	_	_	_	_
5	alpha,25-dihydroxyvitamin	alpha,25-dihydroxyvitamin	_	_	_	_	_	_	_
6	D3	d3	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	1,25(OH)2D3)	1,25(oh)2d3)	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	its	its	_	_	_	_	_	_	_
11	receptor	receptor	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	these	these	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	lines	line	_	_	_	_	_	_	_
16	was	be	_	_	_	_	_	_	_
17	compared	compare	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	binding	bind	_	_	_	_	_	_	_
20	studies	study	_	_	_	_	_	_	_
21	using	use	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	T-lymphocyte	T-lymphocyte	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	line	line	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	S-LB1	S-LB1	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	from	from	_	_	_	_	_	_	_
30	a	a	_	_	_	_	_	_	_
31	normal	normal	_	_	_	_	_	_	_
32	individual.	individual.	_	_	_	_	_	_	_
33	The	the	_	_	_	_	_	_	_
34	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
35	receptor	receptor	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	S-LB1	S-LB1	_	_	_	_	_	_	_
38	was	be	_	_	_	_	_	_	_
39	comparable	comparable	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	well-characterized	well-characterized	_	_	_	_	_	_	_
43	chick	chick	_	_	_	_	_	_	_
44	intestinal	intestinal	_	_	_	_	_	_	_
45	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
46	receptor	receptor	_	_	_	_	_	_	_
47	in	in	_	_	_	_	_	_	_
48	terms	term	_	_	_	_	_	_	_
49	of	of	_	_	_	_	_	_	_
50	its	its	_	_	_	_	_	_	_
51	ligand	ligand	_	_	_	_	_	_	_
52	binding	binding	_	_	_	_	_	_	_
53	affinity	affinity	_	_	_	_	_	_	_
54	and	and	_	_	_	_	_	_	_
55	capacity	capacity	_	_	_	_	_	_	_
56	,	,	_	_	_	_	_	_	_
57	its	its	_	_	_	_	_	_	_
58	mobility	mobility	_	_	_	_	_	_	_
59	on	on	_	_	_	_	_	_	_
60	5-20	5-20	_	_	_	_	_	_	_
61	%	%	_	_	_	_	_	_	_
62	sucrose	sucrose	_	_	_	_	_	_	_
63	gradients	gradient	_	_	_	_	_	_	_
64	,	,	_	_	_	_	_	_	_
65	and	and	_	_	_	_	_	_	_
66	its	its	_	_	_	_	_	_	_
67	adsorption	adsorption	_	_	_	_	_	_	_
68	to	to	_	_	_	_	_	_	_
69	and	and	_	_	_	_	_	_	_
70	elution	elution	_	_	_	_	_	_	_
71	properties	property	_	_	_	_	_	_	_
72	from	from	_	_	_	_	_	_	_
73	DNA-cellulose	DNA-cellulose	_	_	_	_	_	_	_
74	.	.	_	_	_	_	_	_	_

1	Three	three	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	lines	line	_	_	_	_	_	_	_
4	established	establish	_	_	_	_	_	_	_
5	from	from	_	_	_	_	_	_	_
6	patients	patient	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	VDDR-II	VDDR-II	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	Rh-VDR	Rh-VDR	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	Sh-VDR	Sh-VDR	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	Ab-VDR	Ab-VDR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	showed	show	_	_	_	_	_	_	_
18	no	no	_	_	_	_	_	_	_
19	specific	specific	_	_	_	_	_	_	_
20	binding	binding	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	receptor	receptor	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	treatment	treatment	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	cultured	culture	_	_	_	_	_	_	_
31	cells	cell	_	_	_	_	_	_	_
32	with	with	_	_	_	_	_	_	_
33	1,25(OH)2D3	1,25(OH)2D3	_	_	_	_	_	_	_
34	did	do	_	_	_	_	_	_	_
35	not	not	_	_	_	_	_	_	_
36	stimulate	stimulate	_	_	_	_	_	_	_
37	production	production	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	24,25-dihydroxy-vitamin	24,25-dihydroxy-vitamin	_	_	_	_	_	_	_
40	D3	D3	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	24,25(OH)2D3)	24,25(OH)2D3)	_	_	_	_	_	_	_
43	,	,	_	_	_	_	_	_	_
44	a	a	_	_	_	_	_	_	_
45	response	response	_	_	_	_	_	_	_
46	which	which	_	_	_	_	_	_	_
47	is	be	_	_	_	_	_	_	_
48	diagnostic	diagnostic	_	_	_	_	_	_	_
49	of	of	_	_	_	_	_	_	_
50	the	the	_	_	_	_	_	_	_
51	presence	presence	_	_	_	_	_	_	_
52	of	of	_	_	_	_	_	_	_
53	a	a	_	_	_	_	_	_	_
54	functional	functional	_	_	_	_	_	_	_
55	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
56	receptor	receptor	_	_	_	_	_	_	_
57	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	fourth	fourth	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	line	line	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	A1-VDR	A1-VDR	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	1,25(OH)2D3	1,25(OH)2D3	_	_	_	_	_	_	_
13	had	have	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	low	low	_	_	_	_	_	_	_
16	binding	binding	_	_	_	_	_	_	_
17	capacity	capacity	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	25(OH)D3-24-hydroxylase	25(oh)d3-24-hydroxylase	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	was	be	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	detectable	detectable	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Induction	Induction	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	24,25-(OH)2D3	24,25-(oh)2d3	_	_	_	_	_	_	_
4	synthesis	synthesis	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	1,25(OH)2D3	1,25(OH)2D3	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	observed	observe	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	fifth	fifth	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	line	line	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	designated	designate	_	_	_	_	_	_	_
16	Ro-VDR	Ro-VDR	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	although	although	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	sensitivity	sensitivity	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	hormone	hormone	_	_	_	_	_	_	_
23	treatment	treatment	_	_	_	_	_	_	_
24	was	be	_	_	_	_	_	_	_
25	lower	low	_	_	_	_	_	_	_
26	than	than	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	control	control	_	_	_	_	_	_	_
30	cell	cell	_	_	_	_	_	_	_
31	line	line	_	_	_	_	_	_	_
32	from	from	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	normal	normal	_	_	_	_	_	_	_
35	donor	donor	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	capacity	capacity	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	receptor	receptor	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	1,25(OH)2D3	1,25(OH)2D3	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	low	low	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	Ro-VDR	Ro-VDR	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	all	all	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	lines	line	_	_	_	_	_	_	_
5	where	where	_	_	_	_	_	_	_
6	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
7	binding	bind	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	detectable	detectable	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	had	have	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	typical	typical	_	_	_	_	_	_	_
19	sedimentation	sedimentation	_	_	_	_	_	_	_
20	coefficient	coefficient	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	3.7	3.7	_	_	_	_	_	_	_
23	S	S	_	_	_	_	_	_	_
24	on	on	_	_	_	_	_	_	_
25	sucrose	sucrose	_	_	_	_	_	_	_
26	density	density	_	_	_	_	_	_	_
27	gradient	gradient	_	_	_	_	_	_	_
28	analysis	analysis	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	elution	elution	_	_	_	_	_	_	_
4	properties	property	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	DNA-cellulose	dna-cellulose	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	however	however	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	differed	differ	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	normal	normal	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	Ro-VDR	Ro-VDR	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	A1-VDR	A1-VDR	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	where	where	_	_	_	_	_	_	_
20	elution	elution	_	_	_	_	_	_	_
21	from	from	_	_	_	_	_	_	_
22	DNA-cellulose	DNA-cellulose	_	_	_	_	_	_	_
23	occurred	occur	_	_	_	_	_	_	_
24	at	at	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	lower	low	_	_	_	_	_	_	_
27	salt	salt	_	_	_	_	_	_	_
28	concentration	concentration	_	_	_	_	_	_	_
29	than	than	_	_	_	_	_	_	_
30	is	be	_	_	_	_	_	_	_
31	typical	typical	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
35	receptor	receptor	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	While	while	_	_	_	_	_	_	_
2	Ro-VDR	Ro-VDR	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	showed	show	_	_	_	_	_	_	_
5	typical	typical	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	localization	localization	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	unoccupied	unoccupied	_	_	_	_	_	_	_
11	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	neither	neither	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	unoccupied	unoccupied	_	_	_	_	_	_	_
17	nor	nor	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	occupied	occupied	_	_	_	_	_	_	_
20	receptor	receptor	_	_	_	_	_	_	_
21	from	from	_	_	_	_	_	_	_
22	A1-VDR	A1-VDR	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	was	be	_	_	_	_	_	_	_
25	completely	completely	_	_	_	_	_	_	_
26	localized	localize	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	nucleus	nucleus	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	series	series	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	functional	functional	_	_	_	_	_	_	_
6	studies	study	_	_	_	_	_	_	_
7	we	we	_	_	_	_	_	_	_
8	found	find	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	modulation	modulation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	level	level	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	mRNAs	mrna	_	_	_	_	_	_	_
17	coding	cod	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	both	both	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	c-myc	c-myc	_	_	_	_	_	_	_
22	oncogene	oncogene	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	growth	growth	_	_	_	_	_	_	_
26	factor	factor	_	_	_	_	_	_	_
27	known	know	_	_	_	_	_	_	_
28	as	as	_	_	_	_	_	_	_
29	granulocyte-monocyte	granulocyte-monocyte	_	_	_	_	_	_	_
30	colony	colony	_	_	_	_	_	_	_
31	stimulating	stimulating	_	_	_	_	_	_	_
32	activity	activity	_	_	_	_	_	_	_
33	by	by	_	_	_	_	_	_	_
34	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
35	correlated	correlate	_	_	_	_	_	_	_
36	with	with	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
39	receptor	receptor	_	_	_	_	_	_	_
40	status	status	_	_	_	_	_	_	_
41	of	of	_	_	_	_	_	_	_
42	these	these	_	_	_	_	_	_	_
43	cells	cell	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	Use	use	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	lines	line	_	_	_	_	_	_	_
6	will	will	_	_	_	_	_	_	_
7	facilitate	facilitate	_	_	_	_	_	_	_
8	further	further	_	_	_	_	_	_	_
9	study	study	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	molecular	molecular	_	_	_	_	_	_	_
13	defect(s)	defect(s)	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	receptor	receptor	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	vitamin	vitamin	_	_	_	_	_	_	_
21	D-dependent	d-dependent	_	_	_	_	_	_	_
22	rickets	ricket	_	_	_	_	_	_	_
23	type	type	_	_	_	_	_	_	_
24	II	ii	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	will	will	_	_	_	_	_	_	_
27	allow	allow	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	correlation	correlation	_	_	_	_	_	_	_
30	with	with	_	_	_	_	_	_	_
31	impairment	impairment	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	cellular	cellular	_	_	_	_	_	_	_
34	functions	function	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

